CTT Pharma Corporate Updates
The original release is unavailable here.
CTT Pharmaceutical Holdings, Inc. on 6ix
Earlier from CTT Pharmaceutical
- CTT Parma Updates On Worldwide Patent Portfolio
- CTT Pharma Signs Agreement for New Oral Product Development
- CTT Pharma's Europe Patent Approved
- CTT Pharma's CEO Issues Letter To Shareholders
- CTT Pharma Settles Lawsuit With Aurora
Later from CTT Pharmaceutical
- CTT Pharma Appoints David Paton, former Head Of Innovation at BAT, as Senior Advisor
- CTT Pharma News Release
- CTT Pharma and Johns Hopkins University Partner for $15 Million NIH Grant
- CTT Pharma CEO Announces 8.1% Stock Ownership In Company
- CTT Pharma Updates On Diabetes Drug Grant
Follow CTT Pharmaceutical into a list and get an email when it puts out news.
Follow CTT Pharmaceutical